Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.48 BRL | -0.96% | -1.63% | -19.73% |
Mar. 08 | Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024 | |
Mar. 07 | Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.73% | 1.53B | A- | ||
-17.86% | 8.35B | B+ | ||
+39.76% | 3.58B | C+ | ||
-8.06% | 2.47B | - | ||
-38.71% | 2.46B | B- | ||
-7.96% | 2.36B | B- | ||
-14.62% | 1.78B | C- | ||
-40.78% | 1.21B | C+ | ||
+8.32% | 1.12B | B+ | ||
-10.43% | 1.09B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FLRY3 Stock
- Ratings Fleury S.A.